Skip to main content
. 2016 Oct 10;8(5):7328–7335. doi: 10.18632/oncotarget.12551

Figure 1. A) Low power (2X) of a RCC with B)clear–cell and C) rhabdoid components (20X) and two different mutational patterns.

Figure 1

D) The rhabdoid component showed the p.V272L hot-spot mutation of the TP53 gene; while E) the clear cell counterpart harbored the missense p.Q96FS*63 mutation of the VHL1 gene.